Medimaps Group and Radiobotics Announce Strategic Merger to Expand AI-Driven Musculoskeletal Imaging Portfolio
01/12/2025 -
Media - Press releases
Medimaps Group to Unveil TBS Reveal – Opportunistic Screening AI Software on X-Ray – at RSNA
29/07/2025 -
Media - Press releases
Medimaps Group Collaborates with National Spine Health Foundation to Advance AI-Based Bone Fragility Assessment in Spine Surgery
03/07/2025 -
Media - Press releases
Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment
10/06/2025 -
Media - Press releases
Medimaps Group expands in the U.S. with the launch of TBS Osteo next-generation software for advanced bone microarchitecture assessment
01/05/2025 -
Media - Press releases
SimonMed Launches DEXA + TBS: A New Standard for Bone Health
27/01/2025 -
Media - Press releases
Medimaps Breaks New Ground in Fracture Risk Assessment with FDA Clearance and MDR Certification for TBS Osteo Next Generation Software
27/09/2024 -
Media - Press releases
Award-winning study confirms Medimaps Group new AI software accurately assesses bone fragility from routine X-rays
04/09/2023 -
Press releases
Medimaps Group receives EU certification under the medical device regulation
05/07/2023 -
Press releases
Medimaps Group deep-tech TBS software endorsed by international experts working group to inform osteoporosis management decisions for the benefit of the patient
01/03/2023 -
Press releases
Medimaps Group presents data showing new AI approach enhances osteoporosis diagnosis and monitoring at ECR 2023
28/11/2022 -
Press releases
Medimaps Group appoints Meinhard F. Schmidt as Board Chairman; adds Anne Le Grand and five additional board members
14/11/2022 -
Press releases
Medimaps Group announces partnership with OsteoSys to bring trabecular bone score to Korea’s leading bone densitometry platform
04/03/2022 -
Press releases
Medical reimbursement now available for trabecular bone score (TBS), an advanced medtech solution with artificial intelligence capabilities, for osteoporosis fracture risk assessment
01/01/2021 -
Press releases
Medimaps Group raises $20 million to expand and to commercialize AI product portfolio for bone health assessment utilizing routine medical images
medimaps group SA
Chemin du Champ-des-Filles 36A
1228 Plan-les-Ouates
Geneva, Switzerland
Medimaps Group USA LLC
1201N Market Street
Suite 111
Wilmington, DE 19801, United States
Medimaps Group has been certified by DNV to ISO 13485:2016 under certificate number MDR C831120 CE 2460. TBS iNsight and TBS Reveal are trademarks of Medimaps Group. TBS iNsight is cleared for sale in the US.
Please note that you are now accessing content reserved for healthcare professionals only. By accepting, you confirm that you are a healthcare professional.
Click “OK” to confirm you are a Healthcare Professional.